SRDX Surmodics, Inc. Stock Quote

SRDX [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	1242.17	EPS (ttm)	0.05	Insider Own	3.30%	Shs Outstand	13.67M	Perf Week	1.71%
Market Cap	793.10M	Forward P/E	59.03	EPS next Y	0.97	Insider Trans	-5.34%	Shs Float	13.27M	Perf Month	4.02%
Income	0.70M	PEG	124.22	EPS next Q	0.63	Inst Own	89.80%	Short Float	2.66%	Perf Quarter	28.81%
Sales	94.50M	P/S	8.39	EPS this Y	-85.20%	Inst Trans	0.23%	Short Ratio	6.68	Perf Half Y	42.78%
Book/sh	9.76	P/B	5.85	EPS next Y	159.52%	ROA	0.40%	Target Price	70.75	Perf Year	71.18%
Cash/sh	3.88	P/C	14.71	EPS next 5Y	10.00%	ROE	0.50%	52W Range	33.00 - 58.60	Perf YTD	31.30%
Dividend	-	P/FCF	108.64	EPS past 5Y	-38.20%	ROI	1.00%	52W High	-2.49%	Beta	1.06
Dividend %	-	Quick Ratio	6.00	Sales past 5Y	8.90%	Gross Margin	83.20%	52W Low	73.15%	ATR	2.02
Employees	370	Current Ratio	6.50	Sales Q/Q	-1.30%	Oper. Margin	-1.00%	RSI (14)	61.87	Volatility	3.45% 3.81%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-286.50%	Profit Margin	0.70%	Rel Volume	0.58	Prev Close	57.67
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 09 BMO	Payout	0.00%	Avg Volume	52.90K	Price	57.14
Recom	1.50	SMA20	4.56%	SMA50	9.51%	SMA200	28.23%	Volume	30,820	Change	-0.92%

Jul-23-20

Upgrade

Needham

Hold → Buy

Dec-11-19

Downgrade

Needham

Buy → Hold

Nov-01-19

Downgrade

Lake Street

Buy → Hold

$75 → $50

Aug-01-19

Reiterated

Needham

Buy

$65 → $68

May-02-19

Reiterated

Needham

Buy

$74 → $65

May-02-19

Reiterated

Lake Street

Buy

$90 → $75

Feb-21-19

Reiterated

Needham

Buy

$69 → $74

May-16-18

Reiterated

Needham

Buy

$46 → $55

Mar-01-18

Upgrade

Sidoti

Neutral → Buy

Feb-28-18

Reiterated

Lake Street

Buy

$35 → $38

Feb-28-18

Initiated

Needham

Buy

$42

Jul-14-17

Initiated

Lake Street

Buy

$40

Nov-21-16

Downgrade

Barrington Research

Outperform → Mkt Perform

Oct-06-16

Downgrade

Sidoti

Buy → Neutral

May-03-16

Reiterated

Barrington Research

Outperform

$27 → $30

Aug-06-15

Reiterated

Barrington Research

Outperform

$28 → $29

Mar-27-15

Initiated

Dougherty & Company

Buy

$33

Feb-25-14

Initiated

Laidlaw

Buy

$30

Aug-01-13

Upgrade

Feltl & Co.

Buy → Strong Buy

$31.25

Nov-12-12

Reiterated

Barrington Research

Outperform

$20 → $22

Apr-07-21 11:40AM	PAHC or SRDX: Which Is the Better Value Stock Right Now? Zacks
Apr-06-21 01:07PM	BD's (BDX) $65M Investment to Boost Supply-Chain Strength Zacks
11:31AM	Here's Why You Should Retain Luminex (LMNX) Stock for Now Zacks
Apr-01-21 08:42AM	Buy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021 Zacks
08:30AM	Surmodics Announces Successful First Patient Uses of Two Sublime Radial Access Platform Devices Business Wire
Mar-31-21 12:26PM	BD (BDX) Receives FDA EUA for Combination Rapid Antigen Test Zacks
Mar-30-21 12:19PM	PerkinElmer's (PKI) Horizon Discovery Broadens Portfolio Zacks
Mar-23-21 07:30PM	Sidoti Virtual Investor Conference ACCESSWIRE
Mar-17-21 04:05PM	Surmodics to Present at Sidoti & Company Virtual Investor Conference Business Wire
Mar-16-21 12:20PM	Why You Should Add Surmodics (SRDX) to Your Portfolio Now Zacks
Feb-10-21 11:31AM	Surmodics (SRDX) Q1 Earnings Beat Estimates, Revenues Miss Zacks
Feb-09-21 04:00PM	Surmodics Inc (SRDX) Q1 2021 Earnings Call Transcript Motley Fool +13.98%
08:45AM	SurModics (SRDX) Beats Q1 Earnings Estimates Zacks
07:44AM	Recap: Surmodics Q1 Earnings Benzinga
07:30AM	Surmodics Reports First Quarter Fiscal 2021 Results Business Wire
Feb-05-21 08:12AM	How Does Surmodics' (NASDAQ:SRDX) CEO Pay Compare With Company Performance? Simply Wall St.
Feb-04-21 08:30AM	Surmodics to Host Virtual Annual Meeting of Shareholders Business Wire
Feb-02-21 12:31PM	Analysts Estimate SurModics (SRDX) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-01-21 08:30AM	Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9 Business Wire
Jan-25-21 08:25AM	12-Month Data from Surmodics TRANSCEND Trial Presented at LINC 2021 Event Business Wire
Jan-20-21 11:40AM	PAHC vs. SRDX: Which Stock Should Value Investors Buy Now? Zacks
Jan-12-21 08:05AM	Surmodics Announces TRANSCEND Trial 12-Month Data to be Presented at LINC 2021 Virtual Event Business Wire +6.69%
Dec-16-20 10:28AM	Is SRDX A Good Stock To Buy Now? Insider Monkey
Dec-04-20 11:31AM	Why Is SurModics (SRDX) Up 6.4% Since Last Earnings Report? Zacks
Nov-09-20 08:05AM	6-Month Data From the Surmodics Avess AV Fistula DCB First-in-Human Study Presented at VIVA 2020 Business Wire +6.17%
Nov-05-20 09:13AM	Surmodics (SRDX) Reports Q4 Loss, Revenues Beat Estimates Zacks -5.01%
Nov-04-20 06:05PM	SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:33PM	Recap: Surmodics Q4 Earnings Benzinga
04:05PM	Surmodics Reports Fourth Quarter Fiscal 2020 Results Business Wire
Oct-28-20 12:32PM	Earnings Preview: SurModics (SRDX) Q4 Earnings Expected to Decline Zacks
Oct-27-20 08:30AM	Surmodics to Webcast Fourth Quarter Fiscal 2020 Earnings Conference Call on November 4 Business Wire
Oct-22-20 12:33PM	Earnings Preview: SurModics (SRDX) Q4 Earnings Expected to Decline Zacks
Oct-12-20 11:40AM	NUVA or SRDX: Which Is the Better Value Stock Right Now? Zacks
Sep-29-20 09:06AM	Surmodics' Pounce Thrombus Retrieval System Gets FDA Nod Zacks
Sep-23-20 08:30AM	Surmodics Receives FDA 510(k) Clearance for Pounce Thrombus Retrieval System Business Wire
Sep-15-20 08:20AM	Here's Why You Should Add Surmodics to Your Portfolio Now Zacks
Sep-04-20 11:31AM	Why Is SurModics (SRDX) Down 7.3% Since Last Earnings Report? Zacks
Aug-10-20 08:17AM	Surmodics (SRDX) Q3 Earnings and Revenues Beat Estimates Zacks
Aug-07-20 11:39AM	Needham: Time to Turn Bullish on These 2 Stocks TipRanks
Aug-05-20 06:15PM	SurModics (SRDX) Q3 Earnings and Revenues Top Estimates Zacks
04:05PM	Surmodics Reports Third Quarter Fiscal 2020 Results Business Wire
04:05PM	Surmodics Receives FDA 510(k) Clearance for Sublime Radial Access 0.014 RX PTA Dilatation Catheter Business Wire
Jul-29-20 12:33PM	Analysts Estimate SurModics (SRDX) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-28-20 08:30AM	Surmodics to Webcast Third Quarter Fiscal 2020 Earnings Conference Call on August 5 Business Wire
Jul-22-20 12:32PM	Earnings Preview: SurModics (SRDX) Q3 Earnings Expected to Decline Zacks
Jul-14-20 11:40AM	VREX vs. SRDX: Which Stock Is the Better Value Option? Zacks
Jul-08-20 08:39AM	BD Unveils BD PurPrep Patient Preoperative Skin Preparation Zacks
07:46AM	Here's Why You Should Retain Avanos Medical Stock for Now Zacks
Jul-05-20 05:45PM	Do Hedge Funds Love SurModics, Inc. (SRDX)? Insider Monkey
Jul-01-20 08:49AM	NextGen Virtual Visits Offers Remote Eye Care Facilities Zacks
Jun-30-20 06:57AM	LHC Group Inks Deal With Orlando Health to Improve HCBS Zacks
Jun-29-20 10:12AM	Top Ranked Momentum Stocks to Buy for June 29th Zacks +8.07%
08:40AM	Quidel (QDEL) Catches Eye: Stock Jumps 6.3% Zacks
08:30AM	Why Surmodics (SRDX) Could Be Positioned for a Surge Zacks
08:20AM	Ecolab's Unit Unveils Test Kit for Cooling Water Management Zacks
Jun-26-20 09:09AM	Top Ranked Momentum Stocks to Buy for June 26th Zacks
Jun-25-20 07:53AM	Here's Why You Should Add Surmodics to Your Portfolio Now Zacks
Jun-23-20 09:24AM	Allscripts' (MDRX) Veradigm Partners with PAN Foundation Zacks
Jun-17-20 06:28AM	ABIOMED Unveils Digital Platform CAMP PCI for CAD Treatment Zacks
Jun-16-20 08:45AM	Here's Why You Should Add HMS Holdings to Your Portfolio Now Zacks
Jun-12-20 12:20PM	Can SurModics (SRDX) Run Higher on Rising Earnings Estimates? Zacks
Jun-10-20 09:50AM	Surmodics Gets CE Mark for SurVeil Drug-Coated Balloon Zacks
Jun-09-20 08:02AM	Here's Why You Should Retain LHC Group (LHCG) Stock Now Zacks
Jun-08-20 08:30AM	Surmodics Receives CE Mark for its SurVeil Drug Coated Balloon Business Wire +5.56%
Jun-03-20 10:07AM	Amedisys (AMED) Broadens Hospice Base With AseraCare Buyout Zacks
Jun-02-20 11:11AM	Tandem Diabetes Rides on Control-IQ Amid Coronavirus Crisis Zacks
10:24AM	HEXO in Focus: Stock Moves 9% Higher Zacks
Jun-01-20 09:59AM	Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio Zacks
May-29-20 11:31AM	SurModics (SRDX) Up 1.1% Since Last Earnings Report: Can It Continue? Zacks
09:18AM	Zimmer Biomet Faces Procedure Delays, Long-Term Potential Solid Zacks
May-28-20 09:43AM	Here's Why You Should Hold on to Chemed (CHE) Stock for Now Zacks
May-27-20 10:03AM	IDEXX Sees Higher Clinical Visits Despite Coronavirus Crisis Zacks
May-26-20 10:02AM	Henry Schein Sales Drop on Coronavirus Woes, Costs Rise Zacks
08:51AM	Here's Why You Should Add Surmodics to Your Portfolio Now Zacks
May-20-20 07:43AM	Medtronic Launches Kyphon Cannula for Balloon Kyphoplasty Zacks
May-19-20 10:47AM	ResMed (RMD) Launches Digital Tool for Remote Mask Selection Zacks
08:58AM	Organigram (OGI) Catches Eye: Stock Jumps 11.7% Zacks
May-18-20 11:55AM	Myriad's (MYGN) EndoPredict Grows Amid Coronavirus Mayhem Zacks
11:13AM	Hologic's Second Molecular Test Gets EUA to Detect Coronavirus Zacks
May-14-20 08:30AM	Surmodics Names Gordon Weber as Senior Vice President of Legal, General Counsel and Secretary Business Wire
May-01-20 10:31AM	SurModics (SRDX) Q2 2020 Earnings Call Transcript Motley Fool
Apr-30-20 09:24PM	Edited Transcript of SRDX earnings conference call or presentation 29-Apr-20 9:00pm GMT Thomson Reuters StreetEvents
10:49AM	Surmodics (SRDX) Q2 Earnings and Revenues Beat Estimates Zacks
Apr-29-20 07:05PM	SurModics (SRDX) Surpasses Q2 Earnings and Revenue Estimates Zacks
04:05PM	Surmodics Reports Second Quarter Fiscal 2020 Results and Provides COVID-19 Pandemic Update Business Wire
Apr-27-20 08:28AM	AMN Healthcare Inks Deal to Address Healthcare System Needs Zacks
Apr-22-20 12:31PM	Earnings Preview: SurModics (SRDX) Q2 Earnings Expected to Decline Zacks
Apr-21-20 02:10PM	Did Surmodics' (NASDAQ:SRDX) Share Price Deserve to Gain 57%? Simply Wall St.
08:30AM	Surmodics to Webcast Second Quarter Fiscal 2020 Earnings Conference Call on April 29 Business Wire
Apr-20-20 08:27AM	Here's Why You Should Retain Accuray in Your Portfolio Zacks
Apr-15-20 08:26AM	Intersect Posts Preliminary Q1 Results, Withdraws '20 View Zacks
Apr-09-20 09:35AM	Bio-Rad Rides on International Expansion Amid Cost Concerns Zacks
Apr-02-20 07:11AM	Here's Why You Should Add Surmodics to Your Portfolio Now Zacks
Mar-21-20 10:54AM	Why Surmodics, Inc.'s (NASDAQ:SRDX) CEO Pay Matters To You Simply Wall St.
Mar-06-20 11:30AM	SurModics (SRDX) Down 22.1% Since Last Earnings Report: Can It Rebound? Zacks
Feb-20-20 09:54AM	Should You Be Worried About Surmodics, Inc.'s (NASDAQ:SRDX) 5.2% Return On Equity? Simply Wall St.
Feb-10-20 06:29PM	Edited Transcript of SRDX earnings conference call or presentation 5-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-06-20 10:03AM	Surmodics (SRDX) Q1 Earnings Beat Estimates, Revenues Miss Zacks
08:35AM	Surmodics to Host Virtual Annual Meeting of Shareholders Business Wire
Feb-05-20 06:25PM	SurModics (SRDX) Surpasses Q1 Earnings Estimates Zacks

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
OLSON CHARLES W	Senior VP of Bus Dev, Med Dev	Mar 31	Sale	56.75	4,759	270,073	42,740	Apr 02 02:30 PM
Maharaj Gary R	President & CEO	Mar 01	Sale	52.06	4,000	208,259	164,713	Mar 03 06:12 PM
KNIGHT SUSAN E	Director	Feb 26	Option Exercise	21.31	5,576	118,825	34,290	Mar 02 04:06 PM
OLSON CHARLES W	Senior VP of Bus Dev, Med Dev	Feb 26	Option Exercise	20.46	13,533	276,827	56,638	Mar 02 04:07 PM
KNIGHT SUSAN E	Director	Feb 26	Sale	52.36	5,576	291,955	28,714	Mar 02 04:06 PM
Arens Timothy J.	Chief Financial Officer	Feb 24	Option Exercise	20.44	10,973	224,242	65,076	Feb 26 04:02 PM
BEDOYA JOSE H	Director	Feb 23	Sale	50.68	1,497	75,868	22,817	Feb 25 04:33 PM
Stich Joseph J.	SVP, HR and GM, IVD	Feb 16	Sale	51.69	2,500	129,237	48,062	Feb 18 04:37 PM
KALICH RONALD B SR	Director	Feb 12	Option Exercise	26.46	4,098	108,433	23,504	Feb 16 04:50 PM
Maharaj Gary R	President & CEO	Feb 11	Option Exercise	22.36	82,264	1,839,571	224,406	Feb 16 04:52 PM
Maharaj Gary R	President & CEO	Feb 01	Sale	44.81	3,000	134,423	142,142	Feb 03 04:14 PM
Stich Joseph J.	SVP, HR and GM, IVD	Jan 05	Sale	45.00	2,500	112,500	50,562	Jan 07 04:37 PM
Maharaj Gary R	President & CEO	Jan 04	Sale	43.96	2,000	87,926	145,142	Jan 06 04:25 PM
BEDOYA JOSE H	Director	Nov 17	Option Exercise	22.58	3,575	80,724	25,325	Nov 19 05:06 PM
DANTZKER DAVID	Director	Nov 10	Option Exercise	22.58	3,575	80,724	30,471	Nov 13 04:20 PM
Maharaj Gary R	President & CEO	Sep 01	Sale	45.07	3,000	135,206	135,399	Sep 03 05:06 PM
Stich Joseph J.	SVP, HR and GM, IVD	Aug 19	Sale	46.71	2,500	116,781	51,570	Aug 21 03:20 PM
Maharaj Gary R	President & CEO	Aug 03	Sale	47.44	3,000	142,334	138,142	Aug 05 04:28 PM
Stich Joseph J.	SVP, HR and GM, IVD	Jul 22	Option Exercise	22.58	12,612	284,779	63,488	Jul 24 05:24 PM
Maharaj Gary R	President & CEO	Jul 01	Sale	43.02	2,000	86,037	141,142	Jul 06 06:10 PM
Stich Joseph J.	SVP, HR and GM, IVD	Jun 09	Sale	45.00	2,500	112,500	51,499	Jun 11 05:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience